Every transplant begins as a race against time. Once an organ leaves the body, its condition begins to decline. For decades, static cold storage, where an organ is placed on ice, has been the standard ...
Bridge to Life has received FDA De Novo clearance for its VitaSmart hypothermic oxygenated perfusion (HOPE) system for liver ...
Bridge to Life™ Ltd., a global innovator in organ preservation and perfusion technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the ...
The FDA clearance enables the commercial use of VitaSmart (TM) for hypothermic oxygenated perfusion of donor livers following static cold storage and prior to transplantation, providing a clear, ...
Bridge To Lifetm Secures FDA De Novo Clearance For Vitasmarttm Hypothermic Oxygenated Perfusion (HOPE) System, The First Device Cleared In The U.S. For Hypothermic Oxygenated Perfusion Of Donor Livers ...
Bridge to Life™ Ltd., a global innovator in organ preservation and perfusion technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results